CN108939078A - It is a kind of with treatment tinnitus and the preparation of ear healthcare function and preparation method thereof - Google Patents
It is a kind of with treatment tinnitus and the preparation of ear healthcare function and preparation method thereof Download PDFInfo
- Publication number
- CN108939078A CN108939078A CN201810854373.3A CN201810854373A CN108939078A CN 108939078 A CN108939078 A CN 108939078A CN 201810854373 A CN201810854373 A CN 201810854373A CN 108939078 A CN108939078 A CN 108939078A
- Authority
- CN
- China
- Prior art keywords
- specifically
- ear
- tinnitus
- preparation
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000009205 Tinnitus Diseases 0.000 title claims abstract description 133
- 231100000886 tinnitus Toxicity 0.000 title claims abstract description 133
- 238000002360 preparation method Methods 0.000 title claims abstract description 93
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 83
- 230000006870 function Effects 0.000 claims abstract description 51
- 239000003814 drug Substances 0.000 claims abstract description 50
- 210000004027 cell Anatomy 0.000 claims abstract description 46
- 230000036541 health Effects 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 29
- 230000017531 blood circulation Effects 0.000 claims abstract description 27
- 239000000463 material Substances 0.000 claims abstract description 26
- 230000001737 promoting effect Effects 0.000 claims abstract description 25
- 230000035790 physiological processes and functions Effects 0.000 claims abstract description 22
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 21
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 21
- 239000000556 agonist Substances 0.000 claims abstract description 20
- 230000001413 cellular effect Effects 0.000 claims abstract description 20
- 230000008569 process Effects 0.000 claims abstract description 15
- 239000000284 extract Substances 0.000 claims description 142
- 239000000203 mixture Substances 0.000 claims description 81
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 64
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 62
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 59
- 235000019441 ethanol Nutrition 0.000 claims description 54
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 53
- 239000011734 sodium Substances 0.000 claims description 53
- 229910052708 sodium Inorganic materials 0.000 claims description 53
- 229940088594 vitamin Drugs 0.000 claims description 44
- 229930003231 vitamin Natural products 0.000 claims description 44
- 235000013343 vitamin Nutrition 0.000 claims description 44
- 239000011782 vitamin Substances 0.000 claims description 44
- 241000411851 herbal medicine Species 0.000 claims description 43
- 235000015424 sodium Nutrition 0.000 claims description 43
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 42
- 231100000252 nontoxic Toxicity 0.000 claims description 42
- 230000003000 nontoxic effect Effects 0.000 claims description 42
- 235000002949 phytic acid Nutrition 0.000 claims description 42
- 244000046146 Pueraria lobata Species 0.000 claims description 39
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 39
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 36
- 241000180649 Panax notoginseng Species 0.000 claims description 36
- 238000009472 formulation Methods 0.000 claims description 34
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 33
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 33
- 239000002253 acid Substances 0.000 claims description 33
- 239000004615 ingredient Substances 0.000 claims description 33
- 239000004302 potassium sorbate Substances 0.000 claims description 33
- 235000010241 potassium sorbate Nutrition 0.000 claims description 33
- 229940069338 potassium sorbate Drugs 0.000 claims description 33
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 32
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 32
- 229960003080 taurine Drugs 0.000 claims description 32
- 235000011478 zinc gluconate Nutrition 0.000 claims description 32
- 239000011670 zinc gluconate Substances 0.000 claims description 32
- 229960000306 zinc gluconate Drugs 0.000 claims description 32
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 31
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 31
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 31
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 31
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 claims description 31
- 229960000458 allantoin Drugs 0.000 claims description 31
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 31
- 229930182470 glycoside Natural products 0.000 claims description 31
- 150000002338 glycosides Chemical class 0.000 claims description 31
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 31
- 229960000367 inositol Drugs 0.000 claims description 31
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 31
- 229930182490 saponin Natural products 0.000 claims description 31
- 150000007949 saponins Chemical class 0.000 claims description 31
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 31
- 239000002202 Polyethylene glycol Substances 0.000 claims description 30
- 229920001223 polyethylene glycol Polymers 0.000 claims description 30
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 30
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 30
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 30
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 28
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 28
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 26
- 229950006238 nadide Drugs 0.000 claims description 26
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 22
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 22
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 22
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 22
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 22
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 22
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 22
- IWHVCHNCTHGORM-UHDJGPCESA-M potassium;(e)-3-phenylprop-2-enoate Chemical compound [K+].[O-]C(=O)\C=C\C1=CC=CC=C1 IWHVCHNCTHGORM-UHDJGPCESA-M 0.000 claims description 22
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 21
- 239000000467 phytic acid Substances 0.000 claims description 21
- 229940068041 phytic acid Drugs 0.000 claims description 21
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 21
- 239000011746 zinc citrate Substances 0.000 claims description 21
- 235000006076 zinc citrate Nutrition 0.000 claims description 21
- 229940068475 zinc citrate Drugs 0.000 claims description 21
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 20
- 239000003755 preservative agent Substances 0.000 claims description 20
- 230000002335 preservative effect Effects 0.000 claims description 20
- 239000011576 zinc lactate Substances 0.000 claims description 20
- 229940050168 zinc lactate Drugs 0.000 claims description 20
- 235000000193 zinc lactate Nutrition 0.000 claims description 20
- 239000005515 coenzyme Substances 0.000 claims description 19
- 235000001014 amino acid Nutrition 0.000 claims description 18
- 229940024606 amino acid Drugs 0.000 claims description 18
- 150000001413 amino acids Chemical class 0.000 claims description 18
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 17
- 235000013922 glutamic acid Nutrition 0.000 claims description 17
- 239000004220 glutamic acid Substances 0.000 claims description 17
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 16
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 16
- 229960002685 biotin Drugs 0.000 claims description 16
- 235000020958 biotin Nutrition 0.000 claims description 16
- 239000011616 biotin Substances 0.000 claims description 16
- 229960003966 nicotinamide Drugs 0.000 claims description 16
- 235000005152 nicotinamide Nutrition 0.000 claims description 16
- 239000011570 nicotinamide Substances 0.000 claims description 16
- 229960003512 nicotinic acid Drugs 0.000 claims description 16
- 235000001968 nicotinic acid Nutrition 0.000 claims description 16
- 239000011664 nicotinic acid Substances 0.000 claims description 16
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 15
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 15
- 239000004475 Arginine Substances 0.000 claims description 14
- 239000004471 Glycine Substances 0.000 claims description 14
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 230000004888 barrier function Effects 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 12
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 12
- 238000004090 dissolution Methods 0.000 claims description 12
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 12
- 239000001540 sodium lactate Substances 0.000 claims description 12
- 235000011088 sodium lactate Nutrition 0.000 claims description 12
- 229940005581 sodium lactate Drugs 0.000 claims description 12
- 239000004310 lactic acid Substances 0.000 claims description 11
- 235000014655 lactic acid Nutrition 0.000 claims description 11
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 239000008188 pellet Substances 0.000 claims description 10
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 claims description 10
- 239000004324 sodium propionate Substances 0.000 claims description 10
- 235000010334 sodium propionate Nutrition 0.000 claims description 10
- 229960003212 sodium propionate Drugs 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 8
- -1 glycitols compound Chemical class 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229920003082 Povidone K 90 Polymers 0.000 claims description 7
- 241001072909 Salvia Species 0.000 claims description 7
- 235000017276 Salvia Nutrition 0.000 claims description 7
- 210000000613 ear canal Anatomy 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 244000061520 Angelica archangelica Species 0.000 claims description 5
- 241000928504 Centipeda minima Species 0.000 claims description 5
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 244000246386 Mentha pulegium Species 0.000 claims description 5
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 5
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 5
- 229920003081 Povidone K 30 Polymers 0.000 claims description 5
- 241000951473 Schizonepeta Species 0.000 claims description 5
- SNGZVXPRGLTKNU-RGMNGODLSA-N [Na].C(CC)N[C@@H](CCO)C(=O)O Chemical compound [Na].C(CC)N[C@@H](CCO)C(=O)O SNGZVXPRGLTKNU-RGMNGODLSA-N 0.000 claims description 5
- 235000013339 cereals Nutrition 0.000 claims description 5
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 5
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 5
- 235000001050 hortel pimenta Nutrition 0.000 claims description 5
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 5
- 210000000056 organ Anatomy 0.000 claims description 5
- 230000036961 partial effect Effects 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 229940073490 sodium glutamate Drugs 0.000 claims description 5
- 239000012669 liquid formulation Substances 0.000 claims description 4
- 239000012752 auxiliary agent Substances 0.000 claims description 3
- 210000005056 cell body Anatomy 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 2
- 150000003891 oxalate salts Chemical class 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000004575 stone Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 46
- 229940079593 drug Drugs 0.000 abstract description 20
- 208000003251 Pruritus Diseases 0.000 abstract description 9
- 210000004204 blood vessel Anatomy 0.000 abstract description 9
- 239000002537 cosmetic Substances 0.000 abstract description 9
- 210000003792 cranial nerve Anatomy 0.000 abstract description 9
- 230000003750 conditioning effect Effects 0.000 abstract description 7
- 235000013402 health food Nutrition 0.000 abstract description 7
- 210000003205 muscle Anatomy 0.000 abstract description 6
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 5
- 238000005469 granulation Methods 0.000 abstract description 4
- 230000003179 granulation Effects 0.000 abstract description 4
- 210000000663 muscle cell Anatomy 0.000 abstract description 4
- 230000017074 necrotic cell death Effects 0.000 abstract description 4
- 210000000860 cochlear nerve Anatomy 0.000 abstract description 3
- 230000003915 cell function Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- 201000010099 disease Diseases 0.000 description 20
- 208000024891 symptom Diseases 0.000 description 13
- 210000004556 brain Anatomy 0.000 description 11
- 210000005069 ears Anatomy 0.000 description 10
- 230000000116 mitigating effect Effects 0.000 description 9
- 230000000149 penetrating effect Effects 0.000 description 9
- 235000013305 food Nutrition 0.000 description 7
- BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 6
- 229960002252 carbenoxolone sodium Drugs 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 206010067484 Adverse reaction Diseases 0.000 description 5
- 206010011878 Deafness Diseases 0.000 description 5
- 230000006838 adverse reaction Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 208000032625 disorder of ear Diseases 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000003349 gelling agent Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 3
- 206010014020 Ear pain Diseases 0.000 description 3
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 229960004538 alprazolam Drugs 0.000 description 3
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 3
- 239000004330 calcium propionate Substances 0.000 description 3
- 235000010331 calcium propionate Nutrition 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 208000007176 earache Diseases 0.000 description 3
- 239000003344 environmental pollutant Substances 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 229960000448 lactic acid Drugs 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 231100000719 pollutant Toxicity 0.000 description 3
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229960003975 potassium Drugs 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- VLPIATFUUWWMKC-SNVBAGLBSA-N (2r)-1-(2,6-dimethylphenoxy)propan-2-amine Chemical compound C[C@@H](N)COC1=C(C)C=CC=C1C VLPIATFUUWWMKC-SNVBAGLBSA-N 0.000 description 2
- BUJAGSGYPOAWEI-SECBINFHSA-N (2r)-2-amino-n-(2,6-dimethylphenyl)propanamide Chemical compound C[C@@H](N)C(=O)NC1=C(C)C=CC=C1C BUJAGSGYPOAWEI-SECBINFHSA-N 0.000 description 2
- BGRJTUBHPOOWDU-NSHDSACASA-N (S)-(-)-sulpiride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-NSHDSACASA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 2
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 2
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- DJBNUMBKLMJRSA-UHFFFAOYSA-N Flecainide Chemical compound FC(F)(F)COC1=CC=C(OCC(F)(F)F)C(C(=O)NCC2NCCCC2)=C1 DJBNUMBKLMJRSA-UHFFFAOYSA-N 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- 241000863032 Trieres Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 229960000836 amitriptyline Drugs 0.000 description 2
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 2
- 229960005370 atorvastatin Drugs 0.000 description 2
- 229960000794 baclofen Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 2
- 229960000623 carbamazepine Drugs 0.000 description 2
- MSPRUJDUTKRMLM-UHFFFAOYSA-N caroverine Chemical compound O=C1N(CCN(CC)CC)C2=CC=CC=C2N=C1CC1=CC=C(OC)C=C1 MSPRUJDUTKRMLM-UHFFFAOYSA-N 0.000 description 2
- 229960003355 caroverine Drugs 0.000 description 2
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 2
- 229960003120 clonazepam Drugs 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 2
- 229960000729 cyclandelate Drugs 0.000 description 2
- 229960003572 cyclobenzaprine Drugs 0.000 description 2
- JURKNVYFZMSNLP-UHFFFAOYSA-N cyclobenzaprine Chemical compound C1=CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 JURKNVYFZMSNLP-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229960003529 diazepam Drugs 0.000 description 2
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000010579 first pass effect Methods 0.000 description 2
- 229960000449 flecainide Drugs 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 229960003883 furosemide Drugs 0.000 description 2
- 229960002870 gabapentin Drugs 0.000 description 2
- 235000004554 glutamine Nutrition 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 208000023513 hiccough Diseases 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229960001848 lamotrigine Drugs 0.000 description 2
- PYZRQGJRPPTADH-UHFFFAOYSA-N lamotrigine Chemical compound NC1=NC(N)=NN=C1C1=CC=CC(Cl)=C1Cl PYZRQGJRPPTADH-UHFFFAOYSA-N 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 description 2
- 229960004640 memantine Drugs 0.000 description 2
- OJLOPKGSLYJEMD-URPKTTJQSA-N methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(1e)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate Chemical compound CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC OJLOPKGSLYJEMD-URPKTTJQSA-N 0.000 description 2
- 229960003404 mexiletine Drugs 0.000 description 2
- 229960005249 misoprostol Drugs 0.000 description 2
- 230000007830 nerve conduction Effects 0.000 description 2
- 229960000715 nimodipine Drugs 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 229960002296 paroxetine Drugs 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229960002073 sertraline Drugs 0.000 description 2
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 229960004940 sulpiride Drugs 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 229960002872 tocainide Drugs 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229940074410 trehalose Drugs 0.000 description 2
- 229960002431 trimipramine Drugs 0.000 description 2
- ZSCDBOWYZJWBIY-UHFFFAOYSA-N trimipramine Chemical compound C1CC2=CC=CC=C2N(CC(CN(C)C)C)C2=CC=CC=C21 ZSCDBOWYZJWBIY-UHFFFAOYSA-N 0.000 description 2
- 229960000604 valproic acid Drugs 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- BHWMZEPWQUFLLQ-UHFFFAOYSA-N 2-hydroxypropanoic acid;zinc Chemical compound [Zn].CC(O)C(O)=O BHWMZEPWQUFLLQ-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010048865 Hypoacusis Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 241001126925 Lobata Species 0.000 description 1
- RTHCYVBBDHJXIQ-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine Chemical compound C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 0.000 description 1
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- HCFOYBNXMYSROO-UHFFFAOYSA-N [K].C(C=CC1=CC=CC=C1)(=O)O Chemical compound [K].C(C=CC1=CC=CC=C1)(=O)O HCFOYBNXMYSROO-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- AFCGFAGUEYAMAO-UHFFFAOYSA-N acamprosate Chemical compound CC(=O)NCCCS(O)(=O)=O AFCGFAGUEYAMAO-UHFFFAOYSA-N 0.000 description 1
- 229960004047 acamprosate Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000164 antipsychotic agent Substances 0.000 description 1
- 229940005529 antipsychotics Drugs 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 150000002012 dioxanes Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000000883 ear external Anatomy 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 229960001158 nortriptyline Drugs 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940035613 prozac Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- MOCOXAJEZKHXSF-IHMBCTQLSA-M sodium;(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound [Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MOCOXAJEZKHXSF-IHMBCTQLSA-M 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention belongs to the treatment of ear-nose-throat department otopathy and ear health care technology fields, and in particular to a kind of with treatment tinnitus and the preparation of ear healthcare function and preparation method thereof.This have preparation for the treatment of tinnitus and ear healthcare function be releived by biological tinnitus agent, cell physiological function regulator, cell-protecting, cellular agonist, promoting blood circulation and removing obstruction in channels dose, intelligence hardening agent, antioxidant, cell normal growth is metabolized required agent and auxiliary material uses mild environment-protective process to refine;With " promoting blood circulation and removing obstruction in channels, dispelling wind is had one's ideas straightened out, and is removed necrosis and promoted granulation, anti-inflammatory health care, bacterio static itching-relieving, nourishes ear cranial nerve blood vessel and muscle ", improve the functions such as auditory nerve conducting power and effect.Compared with traditional tinnitus treatment agent, it can not only treat tinnitus, be alternatively arranged as the ear health treatment of ordinary people, conditioning or rehabilitation ear cranial nerve blood vessel and muscle cell function;The effect of existing drug, and have the safety of health food and cosmetics;This product is easy to use, works well.
Description
Technical field
The invention belongs to ear-nose-throat department otopathy treatment and ear health care technology field, and in particular to one kind have treatment tinnitus and
The preparation and preparation method thereof of ear healthcare function.
Background technique
Ear is one of the vitals of human body, and according to tcm theory, ears are the seven apertures (knowledge mouth and nose) that people's weight is wanted
Two, and be directly connected with mouth and nose and brain.So ear diseases can not only injure ear itself, if cannot be rationally or timely
Treatment, it is also possible to other organs can be involved, generate even more serious consequence.Ear is not only important hearing organ and ancients
One of body and the important channel of rehabilitation physical efficiency are improved, the quality of ear function directly decides the health status of human body, due to kind
Kind reason, ear function obstacle disease have become common disease, frequently-occurring disease and chronic disease, such as Hiccough and deaf is influenced on auditory function
Maximum disease, and with advancing age, disease incidence is higher and higher, and the dysacousis patient of over-65s crowd has become row
The fourth-largest chronic disease after bone and arthropathy, hypertension and heart disease.This not only will affect the work of people, life,
Sleep and sociability also directly affect people's health longevity.
Tinnitus refers to that people's generated abnormal sound under the conditions of no any environmental stimuli is felt, often deaf elder generation
Million, cause because of Auditory Function disorder.The tinnitus as caused by lesions of ears often exists simultaneously with deaf or dizziness.Its cause of disease is complicated
Multiplicity, pathogenesis is unclear, there is no the drug and therapy of thoroughly radical cure tinnitus so far.The disease incidence of tinnitus is quite high, according to
Report, about 60% people were once having tinnitus symptom in life, and global incidence is up to 15%-20%, 25.5% U.S.
Adult has tinnitus experience, and European tinnitus illness rate is similar to the U.S., and Norway has 21.3% male and 16.2% women once by ear
Ring puzzlement, and have raising trend with age increase.Account for about the 10-20% of ear-nose-throat department outpatient service with the patient that tinnitus is chief complaint, if pressing
15% estimation, two million people tinnitus are heavier close to 200,000,000 people, and at least by the tinnitus patient in China.Tinnitus can cause severe cardiac
Manage obstacle even commit suiside, it is very harmful, with the factors such as the variation of people's eating habit cause disease of cardiovascular system increase,
Aging of population and industry, the increase of ambient noise, the disease incidence of tinnitus is higher and higher, drastically influence people work,
Life and life quality.So tinnitus has become both at home and abroad clinically one of significant medical problem in the urgent need to address.
In the prior art, mainly there are western modern medicine and TCM Therapy for the treatment method of tinnitus.It is clinically used at present
The chemicals for treating tinnitus mainly include lidocaine (Lidocaine), Tocainide (Tocainide), flecainide
(Flecainide), mexiletine (Mexiletine), carbamazepine (Carbamazepine), Gabapentin
(Gabapentine), Lamotrigine (Lamotrigine), valproic acid (Valproic acid), alprazolam
(Alprazolam), Clonazepam (Clonazepam), first ammonium nitrate determine (Alprazolam), diazepam (Diazepam), A Kan
Acid (Acamprosate), caroverine (Caroverine), Memantine (Memantine), amitriptyline
(Amitriptyline), trimipramine (Trimipramine), go rice for woods (Nortriptyline), Paroxetine
(Paroxetine), Sertraline (Sertraline), Prozac (Fluoxetine), Baclofen (Baclofen), cyclobenzaprine
(Cyclobenzaprine), Misoprostol (Misoprostol), Atorvastatin (Atorvastatin), Nimodipine
(Nimodipine), the medicines such as frusemide (Furosemide), cyclandelate (Cyclandelate), Sulpiride (Sulpiride)
Object.Although these drugs have certain therapeutic effect to tinnitus patient, offer limited effectiveness, and wherein using a large amount of antipsychotics,
Heart rate adjusts drug and hormone medicine, and long-time service is easy to habituation, and has great side effect and security risk.There are also these
Doctor trained in Western medicine administration mode is mainly administered orally or injection system administration, is limited to the body tolerance and drug of different human body
Absorbability, so that the application effect of western modern medicine therapeutic modality exists compared with big limitation.
When traditional Chinese medicine treats tinnitus, mainly based on class medicine pill of tonifying Qi of the kidney, decoction, such as Liuwei Dihuang Wan, deafness
Zuoci pill etc., in addition, there are also Chinese medicine acupunctures or the methods of acupuncture combination medicine and acupoint injection therapy to treat tinnitus.Chinese medicine treats tinnitus
When it is most with tonic, 5 are rhizoma acori graminei, pueraria lobata, Radix Salviae Miltiorrhizae, Radix Astragali, magnetite before the simple medication frequency;Maximum preceding 7
Kind association Chinese medicine is rhizoma acori graminei-pueraria lobata, rhizoma acori graminei-Radix Salviae Miltiorrhizae, rhizoma acori graminei-magnetite, pueraria lobata-Radix Salviae Miltiorrhizae, pueraria lobata-Radix Astragali, Radix Salviae Miltiorrhizae-Huang
Stilbene, rhizoma acori graminei-Radix Astragali.In fact, having many tinnitus patients is not kidney deficiency, using tonic and ineffective, in addition, the master of traditional Chinese medicine
Mode to be administered is also so that its side effect is difficult to avoid that mostly based on oral administration.Although in addition, acupuncture and acupoint injection therapy mode
It is more effective for part tinnitus patient, but due to more demanding to medical staff's professional ability, so that this treatment side
The limitation of formula application is bigger.
In short, it is directed to this persistent ailment of tinnitus, either doctor trained in Western medicine medication or TCM Therapy, though there is certain curative effect,
But many reasons are limited to, curative effect is all not satisfactory, and every kind of method all has compared with big limitation.On the other hand, with human body
Age increases and the decline of body metabolism function, especially because with mobile phone popularize and earphone and high-power audio equipment it is big
Amount application and excessively or ear organ is made be in more and more inferior health person and child and teenager's tinnitus and inferior health person using ear
Also more and more, it is also growing day by day for the importance of ear health care, however, the rare exploitation of ear health treatment, therefore, design,
Develop it is a kind of for tinnitus with obvious treatment, mitigation capability and it is easy to use it is safe, there are certain health care functions to ear brain
Auristilla product have highly important social value and broad application prospect.
Summary of the invention
The application provides a kind of preparation with treatment tinnitus and ear healthcare function.Said preparation has " promoting blood circulation and removing obstruction in channels, dispelling wind
Have one's ideas straightened out, remove necrosis and promote granulation, anti-inflammatory health care, bacterio static itching-relieving nourishes ear cranial nerve blood vessel and muscle " etc. functions.With traditional tinnitus treatment
Agent is compared, it can not only treat tinnitus, moreover it is possible to provide a variety of nutrition and health cares and conditioning or rehabilitation for ear cranial nerve blood vessel and muscle
Effect;The effect of existing drug, and have the safety of health food and cosmetics;It can be used for tinnitus caused by many reasons, ear
Itch, the mitigation and alleviation of the symptoms such as otalgia.It can be not only used for tinnitus patient, but also as the ear health treatment of ordinary people.
Details are as follows for the technical solution that the application is taken.
A kind of preparation with treatment tinnitus and ear healthcare function, said preparation include that biological tinnitus is releived agent, cell physiological
Function regulator, cell-protecting, cellular agonist, promoting blood circulation and removing obstruction in channels dose, intelligence hardening agent, antioxidant, cell normal growth
Be metabolized required agent, under preferable case, said preparation further includes preservative, further preferably in the case of, said preparation further includes invention formulation
Acceptable safety barrier or auxiliary material;
The biology tinnitus is releived agent, and including but not limited to Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, pueraria lobata extract
One of or several arbitrary proportion mixtures may be selected in object and Salvia root P.E;
The cell physiological function regulator makees the physiological function of the relevant soma of ear organ with important adjusting
With being made of vitamins and coenzyme substance;
One of or several arbitrary proportion mixing may be selected in the cell-protecting, including but not limited to trehalose, allantoin
Object;
One of or several arbitrary proportions may be selected in the cellular agonist, including but not limited to ATP disodium, cromoci
Mixture;
Described promoting blood circulation and removing obstruction in channels dose, including but not limited to Notogineng Extract, notoginseng total saponin/glycosides, VB12, may be selected it is one of or
Several arbitrary proportion mixtures;
The intelligence hardening agent, including but not limited to zinc gluconate, zinc lactate, zinc citrate may be selected one of or several
Kind arbitrary proportion mixture;
The antioxidant, including but not limited to taurine, VC sodium, phytic acid, phytate may be selected one of or several any
Scalemic thereof;
The cell normal growth is metabolized required agent, including but not limited to amino acids, lactic acid class, inositol, may be selected wherein one
Kind or the combination of several arbitrary proportions;
The preservative should be food grade preservative, including but not limited to potassium sorbate, dehydroactic acid sodium, potassium cinnamate, Radix Glycyrrhizae
One of or several arbitrary proportion mixtures may be selected in acid, glycyrrhetate, propionate;
The acceptable safety barrier of the invention formulation or auxiliary material, the including but not limited to polyethylene glycol of different molecular weight size
(PEG), the polyvinylpyrrolidone (PVP) or/and other excipient of different molecular weight size may be selected one of or several
Arbitrary proportion mixture;
The polyethylene glycol of the different molecular weight size refers to that molecular weight is the polyethylene glycol of 400-20000 dalton;
The PVP of the different molecular weight size, including but not limited to PVP K15, PVP K30, PVP K60 and PVP K90, selection
One of or several arbitrary proportion mixtures.
The treatment tinnitus and the preparation with ear healthcare function, said preparation are liquor, and the total mass concentration of effective ingredient is
0.5-20.0%, surplus are solvent;Each composition is in terms of mass fraction in effective ingredient, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 1.0-80.0, Rhizoma Acori Graminei extract 0.01-9.0, pueraria lobata extract
Object 0.01-6.0, Salvia root P.E 0.01-6.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 0.01-6.0, vitamin V B2 0.001-1.0, niacinamide 0.01-10.0, VB5 0.01-6.0, VB6
0.01-6.0, niacin 0.01-5.0, Vc 0.01-5.0, Ve 0.001-1.0;
Biotin 0.001-1.0, Co-Q10 0.001-1.0, Coenzyme I 0.001-2.0, Coenzyme I I 0.001-2.0;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 0.01-9.0, allantoin 0.001-
2.0;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 0.01-5.0, cell color
Plain C 0.001-5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
0.01-10.0, notoginseng total saponin/glycosides 0.001-2.0, VB12 0.01-10.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically: zinc gluconate 0.01-4.0,
Zinc lactate 0.01-4.0, zinc citrate 0.01-4.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically: taurine 0.01-5.0, VC sodium 0.01-
5.0, phytic acid 0.01-5.0, phytate 0.01-5.0;
The cell normal growth is metabolized required agent, is made of amino acids, lactic acid class and inositol, specifically:
Arginine 0.001-5.0, serine 0.001-5.0, glycine 0.001-9.0, glutamic acid 0.001-1.0, glutamine
0.01-8.0, lactic acid 0.01-5.0, sodium lactate 0.01-5.0, sodium glutamate 0.01-3.0;Inositol 0.01-6.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate and propionate, tool
For body: potassium sorbate 0.01-2.0, dehydroactic acid sodium 0.01-2.0, potassium cinnamate 0.01-2.0, glycyrrhizic acid 0.01-1.0, sweet
Oxalates 0.01-3.0, propionate 0.01-2.0;
The glycyrrhetate, for arbitrary proportion mixtures one or two kinds of in potassium glycyrrhizana, sodium glycyrrhetate;
The propionate, for arbitrary proportion mixtures one or two kinds of in sodium propionate, calcium propionate.
The acceptable safety barrier of described preparation or auxiliary material, by polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP)
It constitutes, specifically: polyethylene glycol 0.001-12.0, PVP 0.001-10.0.
Described to be used for tinnitus and the preparation with ear healthcare function, in further optimization formula, the gross mass of effective ingredient is dense
Degree is 1.0-18.0%, and surplus is water;Each composition is in terms of mass fraction in effective ingredient, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 2.0-76.0, Rhizoma Acori Graminei extract 0.01-8.0, pueraria lobata extract
Object 0.01-5.0, Salvia root P.E 0.01-5.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 0.01-5.0, vitamin V B2 0.001-0.5, niacinamide 0.01-8.0, VB5 0.01-5.0, VB6
0.01-5.0, niacin 0.01-4.0, Vc 0.01-4.0, Ve 0.01-1.0;Biotin 0.001-0.60, Co-Q10 0.01-
1.0, Coenzyme I 0.01-1.20, Coenzyme I I 0.01-1.60;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 0.01-6.0, allantoin 0.01-
1.0;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 0.01-4.0, cell color
Plain C 0.01-4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
0.01-8.0, notoginseng total saponin/glycosides 0.01-1.80, VB12 0.01-8.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically: zinc gluconate 0.01-3.0,
Zinc lactate 0.01-3.0, zinc citrate 0.01-3.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically: taurine 0.01-4.0, VC sodium 0.01-
4.0, phytic acid 0.01-4.0, phytate 0.01-4.0;
The cell normal growth is metabolized required agent, is made of amino acids, lactic acid class and inositol, specifically: arginine
0.001-4.0, serine 0.001-3.0, glycine 0.001-6.0, glutamic acid 0.01-1.0, glutamine 0.01-5.0, cream
Sour 0.01-3.0, sodium lactate 0.01-4.0, sodium glutamate 0.01-2.0;Inositol 0.01-5.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate and propionate, tool
For body: potassium sorbate 0.01-1.80, dehydroactic acid sodium 0.01-1.80, potassium cinnamate 0.01-1.80, glycyrrhizic acid 0.01-
0.80, glycyrrhetate 0.01-2.0, propionate 0.01-1.80.
The acceptable safety barrier of described preparation or auxiliary material, by polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP)
It constitutes, specifically: polyethylene glycol 0.001-10.0, PVP 0.001-8.0.
The treatment tinnitus and the preparation with ear healthcare function, in terms of dosage form, can be liquid formulation or solid formulation, it is excellent
Choosing uses liquor.Application method are as follows: when being used for tinnitus or ear health care, liquid agent is instilled external ear by earhole by cephalomenia side
In road, a moment is gently massaged, or solid-state agent is uniformly applied near auricle and the basal part of the ear and gently massages a moment, dosage
Aspect, liquor be 1-3 drop/time, 1-3 times/day, every drop volume be 0.02-0.04mL;Solid-state agent be 0.1-2.0g/time, 1-2
Times/day.
Preferably, the preparation of the treatment tinnitus and ear healthcare function, liquor is when being used for tinnitus or ear health care, head
Preparation is instilled in external auditory canal by earhole, massage effect is aided with after drop more preferably by light side;In terms of dosage, 1-3 drop/time, 1-3 times/
Day;Every drop volume is about 0.02-0.04mL, when being used for tinnitus treatment, can take the circumstances into consideration increase and decrease access times and dosage, tinnitus symptom
Just when serious to drip, tinnitus is just dripped less when mitigating, but must not be dripped more;When ear health care, it can take the circumstances into consideration to reduce access times and use
Amount, 1 time a day, 1-3 drop/time, it can uninterruptedly use for a long time;Or solid-state agent is uniformly applied near auricle and the basal part of the ear gently
Massage a moment, dosage be 0.1-1.5g/time, 1-2 times/day.
Present invention also provides a kind of preparation methods for treating tinnitus and the preparation with ear healthcare function.
The preparation method of the treatment tinnitus and the preparation with ear healthcare function, specifically comprises the following steps:
(1) effective ingredient in preparation is divided into 4 groups according to material properties and the convenience of preparation and easy property processed, weighs formula respectively
Middle dosage is spare, specifically:
First group, glycitols compound specifically has: trehalose, inositol, zinc gluconate;
Second group, amino acids specifically have: arginine, serine, glycine, glutamic acid, glutamine, glutamic acid
Sodium;
Third group, vitamin coenzymes class compound, specifically has: vitamin V B1, vitamin V B2, niacinamide, VB5, VB6, niacin,
Vc,Ve;Biotin, Co-Q10, Coenzyme I, Coenzyme I I, VB12;
4th group, the unclassified stores in addition to aqueous solvent specifically has: allantoin, ATP disodium, cromoci, notoginseng total saponin/glycosides,
Taurine, potassium sorbate, dehydroactic acid sodium, lactic acid, sodium lactate, zinc lactate, zinc citrate, VC sodium, phytic acid, phytate, cortex cinnamomi
Sour potassium, glycyrrhizic acid, glycyrrhetate, propionate, Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and pellet
Conopsea extraction;
(2) second group of material weighed in step (1) is placed in reaction kettle, the solvent of part formulation amount, stirring is then added
Dissolution mixes, and stands, and mixture A is obtained after filtering and impurity removing;
(3) third group weighed in step (1) and the 4th group of material are placed in reaction kettle, the molten of part formulation amount is then added
Agent, stirring and dissolving mix, and stand, and mixture B is obtained after filtering and impurity removing;
(4) the mixture B of step (3) is slowly added into the mixture A of step (2), after the completion of addition, is added step (1)
In weighed first group of material component, be eventually adding the solvent and auxiliary agent of remainder formula ratio, dissolution mixes, filtering and impurity removing,
PH=3.5 ~ 8.0 are adjusted, this is formulation products provided herein.
Step (2), step (3), when carrying out dissolution in step (4) and mixing operation, operation temperature should not be greater than 45 DEG C, in order to avoid
The stability of drug effect is influenced, but is also not lower than 10 DEG C, in order to avoid influencing dissolution and mixed effect, preferably 24 DEG C or so are dissolved
Mix operation.
Step (2), step (3), when carrying out dissolution in step (4) and mixing operation, it is preferred to use the homogeneous under vacuum condition
Emulsifying manner is operated, and can preferably ensure mixed effect.
Wherein, the biological tinnitus is releived the Nantural non-toxic Chinese herbal medicine alcohol extract in agent, which is characterized in that the day
Component that right nontoxic Chinese herbal medicine alcohol extract contains following mass fraction is simultaneously made by following processes: 30~90 parts of rhizoma acori graminei,
30~90 parts of Rhizoma Gastrodiae, 40~75 parts of pueraria lobata, 40~75 parts of Radix Salviae Miltiorrhizae, 20~55 parts of Radix Astragali, 30~60 parts of Radix Notoginseng, Radix Angelicae Sinensis 10~50
Part, 30~70 parts of radix saposhnikoviae, 15~70 parts of schizonepeta, 20~80 parts of peppermint, 15~50 parts of the root of Dahurain angelica, 15~50 parts of caulis akebiae, Centipeda minima
15~90 parts;Its process of preparing includes: to weigh the formula Chinese medicine, is crushed to the particle that partial size is grain of rice size, is added
The concentration of 5-20 times of quality of mixture is equivalent to for the ethyl alcohol of 10-90%(V/V), then in including but not limited to vacuum or/and often
It is extracted more than a few hours under the conditions of set temperature is 20-103 DEG C in multi-functional extractor in pressure or/and positive pressure environment, filtering
Extracting solution is collected up to the alcohol extract.
The major design that preparation provided herein functions is theoretical are as follows: a most important theories are " logical pains in traditional Chinese medicine
It is theoretical " ----i.e. general rules do not hurt, pain is not unreasonable.Disease or conditioning body are treated by sensible to be traditional chinese medicine diseases prevention, controls
The basic skills of disease or rehabilitation physical efficiency.Hiccough and deaf is also with transmit sound because of the receiving of ear caused by a variety of causes
The smooth performance of system obstruction of QI between the interior and exterior.On the other hand, it is managed according to " being imitated in Transdermal absorption, external application " in modern medicine and traditional Chinese medicine and pharmacy
By preparation of the invention is to use that there is promoting blood circulation and removing obstruction in channels, dispelling wind to have one's ideas straightened out, remove necrosis and promote granulation, anti-inflammatory health care, bacterio static itching-relieving, nourish ear
The various ingredients of cranial nerve blood vessel and muscle having no toxic side effect are made, and not only have the function for the treatment of the ears diseases such as tinnitus, also
Can have important conditioning and rehabilitative action to ear cranial nerve muscle cell and micro- blood circulation system;Also there is nutrition shield simultaneously
Reason ear brain and the effect for keeping ear brain pleasant.
Compared with traditional treatment tinnitus product or technical method, advantage of the present invention is mainly reflected in following aspects:
(1) product of the present invention is different from the dosage form and administration mode of the Western medicine of traditional treatment tinnitus or Chinese medicine, traditional treatment tinnitus
Western medicine or the dosage form of Chinese medicine be mostly injection and oral agents, the dose for reaching lesion is few, and toxic side effect is big, it is difficult to hide liver
" first pass effect ", product of the present invention be drops or solid gel liniment, do not have not only " first pass effect ", also have " guided missile
The characteristics of drug ", belongs to target administration, and not only dosage is greatly reduced, and effect is obvious, direct and rapid;In addition, its medication
Mode is simple and convenient, not only operates without health care professional, can also use whenever and wherever possible;
(2) compared with traditional treatment tinnitus drug, said preparation is free of any pair of human body toxic side effect or harmful ingredient, it is not
It is only capable for the treatment of and provide the system of a variety of nutrition and health cares and conditioning or rehabilitative action with alleviation tinnitus symptom or a kind of energy for ear brain
Agent;With " promoting blood circulation and removing obstruction in channels, dispelling wind is had one's ideas straightened out, and is removed necrosis and promoted granulation, anti-inflammatory health care, bacterio static itching-relieving, nourishes ear cranial nerve blood vessel and muscle,
The multiple functions such as raising auditory nerve conduction function and vigor ";
(3) health status of human ear can also be evaluated and tentatively be judged to invention formulation;In use, dropped in healthy ear or
After being applied to rear the ear portion, if not having abnormal sensory, penetrating comfort sense of only clearly soothing the spirit then is showing healthy ears just
Often, at this time using being only that preferably strong ear relaxes ear function;If having dropped in tinnitus or potential ear disorder person ear or being applied to auricle
Or after the basal part of the ear, if there is sensible sense of significantly releiving, then show there is heavier ear disease or potential ear disease at this time, and if tinnitus
Or other ear disease diseases are more serious, sensible sense of releiving is more obvious, at this time in use, then playing treatment and mitigation capability;
(4) the preparation method mild condition of invention formulation, simple process, non-environmental-pollution;Since the raw materials used in the present invention is
Biogenic substances component, it is more sensitive to physical and chemical factors such as high temperature and illumination, so, by process optimization, establishing one kind can be with
The simple process of invention formulation, non-environmental-pollution technical method is prepared at normal temperature or low temperature, it is achieving environmental protection and energy saving;
(5) the effect of product of the present invention existing drug, and having can be prolonged and repeated edible or the health food that uses and cosmetics
Safety;Though product of the present invention is externally applied product, its safety both can reach interior (oral) health food (existing adjusting machine
The effect of body function will not also generate any acute, subacute or chronic hazard food to human body) standard, meanwhile, it also complies with
Can long-term external application the national standards such as " cosmetics safety technical specification ".
Specific embodiment
Explanation is further explained to the application below with reference to embodiment.
Embodiment 1
The present embodiment provides a kind of preparation with treatment tinnitus and ear healthcare function, said preparation is liquor, effective ingredient it is total
Mass concentration is 6%, and surplus is water, pH=5.0;Each composition is in terms of mass fraction in effective ingredient, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 40.0, Rhizoma Acori Graminei extract 5.0, kudzu root extract 3.0, pellet
Conopsea extraction 3.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 5.0, vitamin V B2 0.5, niacinamide 8.0, VB5 4.0, VB6 3.0, niacin 4.0, Vc 1.0, Ve
0.4;Biotin 0.6, Co-Q10 0.6, Coenzyme I 0.8, Coenzyme I I 0.9;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 4.5, allantoin 0.9;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 4.0 and cromoci
4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
4.0, notoginseng total saponin/glycosides 0.6, VB12 8.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically: zinc gluconate 2.0, zinc lactate
3.0, zinc citrate 1.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically: taurine 1.0, VC sodium 2.0, phytic acid
2.0, phytate 2.0;
The cell normal growth is metabolized required agent, is made of amino acids, lactic acid class and inositol, specifically:
Arginine 4.0, serine 1.0, glycine 8.0, glutamic acid 0.9, glutamine 7.0, lactic acid 4.0, sodium lactate 4.0, paddy
Propylhomoserin sodium 2.0, inositol 4.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, dipotassium glycyrrhizinate and sodium propionate, tool
For body: potassium sorbate 1.0, dehydroactic acid sodium 0.8, potassium cinnamate 0.8, glycyrrhizic acid 0.5, dipotassium glycyrrhizinate 2.0, sodium propionate 0.9;
The acceptable safety barrier of described preparation or auxiliary material, by polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP) structure
At specifically: polyethylene glycol 400 6.0, Macrogol 4000 2.0, polyethylene glycol 10000 2.0, PEG 20000
2.0, PVP K15 2.0, PVP K30 1.0, PVP K60 0.5 and PVP K90 3.0.
Wherein, the biological tinnitus is releived the Nantural non-toxic Chinese herbal medicine alcohol extract in agent, which is characterized in that the day
Component that right nontoxic Chinese herbal medicine alcohol extract contains following mass fraction is simultaneously made by following processes: 70 parts of rhizoma acori graminei, Rhizoma Gastrodiae
60 parts, 55 parts of pueraria lobata, 55 parts of Radix Salviae Miltiorrhizae, 40 parts of Radix Astragali, 40 parts of Radix Notoginseng, 35 parts of Radix Angelicae Sinensis, 40 parts of radix saposhnikoviae, 40 parts of schizonepeta, 50 parts of peppermint,
30 parts of the root of Dahurain angelica, 30 parts of caulis akebiae, 60 parts of Centipeda minima;Its process of preparing includes: to weigh the formula Chinese medicine, is crushed to partial size
For the particle of grain of rice size, the ethyl alcohol for being equivalent to the concentration of 5-20 times of quality of mixture as 10-90%(V/V) is added, then in true
Altitude set temperature in multi-functional extractor is extracted more than a few hours under the conditions of being 20-75 DEG C, and extracting solution is collected by filtration i.e.
Obtain the alcohol extract.
When specific preparation, that steps are as follows is described for preparation method:
(1) effective ingredient in preparation is divided into 4 groups according to material properties and the convenience of preparation and easy property processed, weighs formula respectively
Middle dosage is spare, specifically:
First group, glycitols compound specifically has: trehalose, inositol, zinc gluconate;
Second group, amino acids specifically have: arginine, serine, glycine, glutamic acid, glutamine, glutamic acid
Sodium;
Third group, vitamin coenzymes class compound, specifically has: vitamin V B1, vitamin V B2, niacinamide, VB5, VB6, niacin,
Vc,Ve;Biotin, Co-Q10, Coenzyme I, Coenzyme I I, VB12;
4th group, unclassified stores, specifically has: allantoin, ATP disodium, cromoci, notoginseng total saponin/glycosides, ox in addition to the solvents
Sulfonic acid, potassium sorbate, dehydroactic acid sodium, lactic acid, sodium lactate, zinc lactate, zinc citrate, VC sodium, phytic acid, phytate, cinnamic acid
Potassium, glycyrrhizic acid, glycyrrhetate, propionate, Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Extract;
(2) second group of material weighed in step (1) is placed in reaction kettle, the solvent of part formulation amount, stirring is then added
Dissolution mixes, and stands, and mixture A is obtained after filtering and impurity removing;
(3) third group weighed in step (1) and the 4th group of material are placed in reaction kettle, the molten of part formulation amount is then added
Agent, stirring and dissolving mix, and stand, and mixture B is obtained after filtering and impurity removing;
(4) the mixture B of step (3) is slowly added into the mixture A of step (2), after the completion of addition, is added step (1)
In weighed first group of material component, be eventually adding the solvent and auxiliary agent of remainder formula ratio, dissolution mixes, filtering and impurity removing,
PH=5.0 are adjusted, this is liquid formulation product provided herein;Thickener Sodium Hyaluronate is added into liquid formulation
It stirs and evenly mixs and can be prepared by solid gel agent;
Step (2), step (3), when carrying out dissolution in step (4) and mixing operation, using under vacuum condition emulsifying mode,
Dissolution is carried out at 30 DEG C or so and mixes operation, preferably to ensure mixed effect.
The safety indexes such as skin irritation and pollutant (heavy metal) to formulation products prepared by the present embodiment are examined
It surveys, as a result (items Testing index listed by table 1,2 is eaten by the health care that can often eat (use) as shown in the following table 1, table 2
The safe standard GB/T 16740-2014 of product and " cosmetics safety technical specification " (version in 2015) new standard execute).
1 skin irritation of table and pollutant (heavy metal) testing result
Index name | Testing result | Health food standard a | Cosmetic standard b | Remarks |
Multiple skin irritation | 0 degree | 2 degree or less | ||
Mercury (Hg), mg/kg | ≤ 0.21 | 0.3 | 1 | |
Arsenic (As), mg/kg | ≤ 0.66 | 1 | 2 | |
Lead (Pb), mg/kg | ≤ 1.07 | 2 | 10 | |
Cadmium (Cd), mg/kg | ≤ 1.62 | 5 | ||
Dioxanes, mg/kg | ≤ 3.28 | 30 | ||
Methanol, mg/kg | ≤ 177 | 2000 | ||
Asbestos | Nothing | It must not detect |
Note: a refers to GB 16740-2014 national food safety standard-health food safety standard;B refers to state food drug
The new edition " cosmetics safety technical specification " (version in 2015) (2015 No. 268) that supervision and management general bureau promulgates, similarly hereinafter.
2 microbiological indicator of table
Project | Index | Health food standard a | Cosmetic standard b |
Total plate count, CFU/g or CFU/mL≤ | 86 | 1000 | 1000 |
Heat-resisting coliform MPN/g, or/mL | Nothing | 0.43 | Nothing |
Staphylococcus aureus/g, or/mL | 0/25g | 0/25g | 0/25g |
Pseudomonas aeruginosa/g, or/mL | 0/25g | 0/25g | 0/25g |
Salmonella/g, or/mL | 0/25g | 0/25g | 0/25g |
Yeast and mold, CFU/g or CFU/mL≤ | 15 | 50 | 50 |
The detection knot of the safety indexes such as the pollutants such as heavy metal of invention formulation and microorganism it can be seen from table 1 and 2
Fruit not only complies fully with the safe standard GB/T 16740-2014 of the health food that can often eat, and also being compliant with can be frequent
Newest " cosmetics safety technical specification " (version in the 2015) standard used.
For the formulation products prepared by the present embodiment, it (is voluntary that inventor, which has carried out part actual human body application experiment,
Person), detailed process is briefly discussed below.
The actual therapeutic application effect of tinnitus patient
The different volunteer of the random tinnitus severity made a definite diagnosis for selecting 133 20-65 years old ages, the course of disease -25 years 1 week is on probation
Product of the present invention;
Application method: the liquid outlet of preparation is directed at external auditory canal, instilled in ear, a moment is massaged after drop by the light side of patients head;With
Amount: 1-3 drop/time, 1-3 times/day, increase and decrease access times and dosage can be taken the circumstances into consideration according to the state of an illness;Curative effect is carried out after 2 months on probation to comment
It is fixed.
Efficacy assessment standard: according to State Food and Drug Administration " in new Chinese medicine guideline of clinical investigations
The guideline of clinical investigations of medicine Drugs in Therapy tinnitus " formulate it is as follows:
Clinical recovery: tinnitus disappears, and auditory rehabilitation is normal, and follow-up 1 month or more not recidivist;
Effective: tinnitus influences work and sleep switchs to only occur in night or quiet environment or persisting tinnitus mitigates as occasionally
Hair, without obvious person hard of hearing;
Effective: tinnitus is switched to occur in noisy environment by influence work and sleep, or by occurring switching to peace and quiet in noisy environment
Occur under environment, or intermittent attack is switched to by duration breaking-out;
Invalid: tinnitus even adds severe one without improvement.
After 2 months, statistical result are as follows: 38 (28.5%) is cured, it is effective 80 (60.2%), it is effective 13 (9.8%),
Invalid 2 (1.5%), total effective rate 98.5%(P < 0.01), achieve ideal effect.
The refreshing ear healthcare applications effect of the strong Er Shuer of Normal volunteers
188 age 20-60 years old non-tinnitus healthy volunteers are selected at random tries out product of the present invention, liquid auristilla and solid-state
Gelling agent each 50% is sent at random, checks feeling after for trier.
Liquor usage: the liquid outlet of preparation is directed at external auditory canal by cephalomenia side, is instilled one and is picked up the ears interior, massage a moment after drop,
It does not drip as control, dosage the other side: 1-3 drop/time, 1-3 times/day, increase and decrease access times and use can be taken the circumstances into consideration according to personal preference
Amount;Solid-state agent is uniformly smeared or cold compress is appropriate near side auricle and the basal part of the ear, gently massages a moment, the other side is as right
According to, dosage be 0.1-1.5g/time, 1-2 times/day;Effective evaluation is carried out after 2 months on probation.
Effective evaluation index or standard: referring to State Food and Drug Administration, " new Chinese medicine clinical research guidance is former
The then guideline of clinical investigations of new Chinese medicine treatment tinnitus " it formulates trier and feels to be divided into following 4 kinds of situations after:
A: feeling pleasant penetrating, listen become apparent from or the sense of hearing is more preferable;
B: feel preferable;
C: feel general or insentience;
D: feel to feel bad.
After 2 months, statistical result are as follows: A 160 (85.1%), B 22 (11.7%), C6 (3.2%), D 0
(0.0%), feel that pleasant penetrating person accounts for 85.1%, in addition feeling preferable person 11.7%, the pleasant rate of panesthesia is 96.8%(P < 0.01),
Achieve good result.
Overall application effect shows: for newly sending out tinnitus patient serious, can experience apparent mitigation after instilling for the first time
With relaxation effect;And be directed to healthy population, instillation one pick up the ears it is interior after, said preparation can allow the healthy human ear being dropped into feel more logical
Thoroughly, more pleasant, most volunteers can also request to drip another ear again.External application near comprehensive drop ear liquor and auricle or the basal part of the ear
The quick-acting that the application effect of solid gel agent can be seen that liquid auristilla is better than external application solid gel agent, but external application is solid
The psychological security that state gelling agent uses is higher than liquid auristilla, and the speed to work does not have that auristilla is fast, but general effect
It is almost the same.If tinnitus is serious or ear itching is felt bad, people are still more willing to use auristilla.
For above-mentioned experiment, the part typical case situation of use process is briefly enumerated and is described below:
(1) Zhang: female, 62 years old, certain government functionary was retired, and for many years, a variety of medical procedures of seeking help are showed no bright for nervous tinnitus
Aobvious curative effect drips ear using product of the present invention, dosage: 1-3 drop/time, it 1-3 times/day, was taken an evident turn for the better, is used using 2 weeks or so
It is almost recovered within 8 weeks or so.
(2) Mr. Wang: male, 54 years old, certain college professor, drug was aggravated with tinnitus before nervous tinnitus more than 10 years, 4 years, in ear
There is serious bored plug sense in outer toot sound your writing and ear canal, the serious ring ear in side must be tightly pressed on ability on pillow at night
It falls asleep, daytime must open vehicle window driving in winter, otherwise can seriously affect because that can not drive with extraneous serious sympathetic response
Work and rest, a variety of medical procedures of seeking help are had no result;Ear is dripped using product of the present invention, dosage: 2-10 drop/time, 1-6 times/day,
It was taken an evident turn for the better using 2 weeks or so;Use invention formulation more than 3 years, not only tinnitus symptom is substantially reduced, can be just so far
Often work and rest, also have no other adverse reactions.
(3) Zhao: female, 51 years old, certain college professor, sudden serious tinnitus 1 day for not knowing reason felt hurricane outside ear intracerebral
Wind your writing and influence thinking ability, drip ear using product of the present invention, dosage: 2-10 drop/time, 1-6 times/day, symptom is used for the first time
Have substantially reduced, was almost recovered using 1 week or so.
(4) Lee: male, 58 years old, certain government functionary, tinnitus more than 10 years, two years ago tinnitus was aggravated, toot sound your writing inside and outside ear
And have serious bored plug sense in ear canal, work and rest are seriously affected, a variety of medical procedures of seeking help are had no result;It is produced using the present invention
Product drip ear, dosage: 2-10 drop/time, it 1-6 times/day, was taken an evident turn for the better using 2 weeks or so, was almost recovered using 8 weeks or so, it is existing
It can work normally and rest, also have no other adverse reactions.
(5) it is honest and just certain: male, 32 years old, certain company manager, health used product of the present invention side to drip ear, dosage: 1-3
Drop/time, 1-3 times/day or each drop 1 time daily morning and evening;Using having pleasant penetrating more invigorative feeling for the first time, the other side is also intended to
It instills;Continuous use 2 months or so, other than pleasant penetrating more invigorative feeling, has no other adverse reactions.
(6) Guo: female, 21 years old, certain company clerk, health dripped ear, dosage: 1-3 using product of the present invention side
Drop/time, 1-3 times/day;Using having pleasant penetrating, to listen clearer feeling for the first time, the other side is also wanted to instill, continuous use 6
Month or so, other than pleasant penetrating more invigorative feeling, have no other adverse reactions.
(7) Sun: male, 47 years old, certain company manager, health was uniformly smeared or cold using product of the present invention gelling agent
Spread near side auricle and the basal part of the ear, gently massage a moment, the other side as control, dosage be 0.3-1.5g/time, 1-2
Times/day;There is pleasant penetrating more invigorative feeling using 3 days;Continuous use 2 months or so penetrating more has spirit in addition to pleasant
Feeling except, have no other adverse reactions.
The formation of the effective prescription of formulation products provided herein is to be moved back based on inventor to nerve, genus of stiff vessel, function
The further investigation and the discovery after analysis of the ears such as row source property tinnitus producing cause and tinnitus symptom, i.e., most of tinnitus all with ear
And the nerve of brain, blood vessel, the functional deterioration of muscle cell or lesion are related, it is also contemplated that ear is communicated with the neighbour of brain and directly
Relationship and ear brain have then determined that sieve to the most important property of people's life and health and the targeting administration mode of invention formulation
The security requirement of component is selected, i.e., is not allow for any toxic side effect under the conditions of existing cognition, then again according to function, first
The biological tinnitus being made of Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract, Salvia root P.E is screened
Releiving agent and has the function of the cell physiological conditioner vitamin and voenzyme of important regulative to the physiological function of soma
Substance allows cell next, having found the cell-protecting trehalose and allantoin for having important protective effect to cell again
Basic substance such as ammonia necessary to capable of thering is the cellular agonist ATP disodium and cromoci of high vigor, cell normal growth to be metabolized
Base acid, lactic acid and inositol etc., promoting blood circulation and removing obstruction in channels dose of Notogineng Extract, notoginseng total saponin/glycosides and VB12, intelligence hardening agent gluconic acid
Zinc, zinc lactate and zinc citrate, it is multi-functional there are also the antioxidant taurine for preventing and treating cell function degeneration raising nerve conductivity
Antioxidant VC sodium, phytic acid and phytate, along with food grade preservative such as potassium sorbate, dehydroactic acid sodium, the cortex cinnamomi of safety
Sour potassium, glycyrrhizic acid, dipotassium glycyrrhizinate and sodium propionate etc., then, physicochemical property and function further according to selected component carry out scientific group
Match, relaxes finally, can treat and alleviate tinnitus using a kind of mild refined one kind of environmentally protective technique but also be good for ear
The safe and efficient preparation of the refreshing ear of ear.
In short, formulation products provided herein be inventor and related volunteer it is long-term it is on probation with verifying as a result,
Said preparation product is refined using mild technique, there is promoting blood circulation and removing obstruction in channels, dispelling wind to have one's ideas straightened out, conserve ear brain, enliven the sense of hearing, go it is saprophytic
Flesh, bacterio static itching-relieving, nourishes ear cranial nerve blood vessel and muscle, improves the effect of auditory nerve conduction function and vigor at anti-inflammatory health care.This
Product are different from conventional medicament, and typical feature is: target administration, effect are obvious;Maintenance combines, based on supporting;Outer suppression disease, it is interior
Repair skin;There is disease that can disappear, it is ill-mannered to prevent;(liquor), which can be dripped, can apply (solid-state agent), easy to use;It is nontoxic, it is safe and efficient.It can
For the mitigation and alleviation of the symptoms such as tinnitus caused by many reasons, ear itching, otalgia, it is hard to be mainly used for neurodegenerative, blood vessel
The mitigation and alleviation of the ears source property tinnitus symptoms such as the property changed, function degeneration.Simultaneously, it can also be used to there is no ear suffer from the age 20 years old with
Upper physical function tends to the gradually strong ear of the people of decline stage, the ear that relaxes, refreshing ear and earflap.Therefore, the function of the existing drug of this product
Effect, and have the safety of food;It can be not only used for tinnitus patient, but also as the ear health treatment of ordinary people, there is preferable society
It can application value.
Embodiment 2
Treatment tinnitus and the formulation products with ear healthcare function, the substantially same embodiment of preparation method provided by the present embodiment
1, only adjustment member formula is as follows:
Said preparation is liquor, and the total mass concentration of effective ingredient is 0.5%, and surplus is water, pH=3.5;Each composition in effective ingredient
In terms of mass fraction, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 1, Rhizoma Acori Graminei extract 0.01, kudzu root extract 0.01, Radix Salviae Miltiorrhizae
Extract 0.01;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 0.01, VB2 0.001, niacinamide 0.01, VB5 0.01, VB6 0.01, niacin 0.01, Vc 0.01, Ve
0.001;Biotin 1.0, Co-Q10 0.001, Coenzyme I 2.0, Coenzyme I I 2.0;
The cell-protecting, is made of trehalose, specifically: trehalose 0.01;
The cellular agonist is made of ATP disodium, specifically: ATP disodium 5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of notoginseng total saponin/glycosides, specifically: notoginseng total saponin/glycosides 2.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically: zinc gluconate 4.0, zinc lactate
4.0, zinc citrate 4.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically: taurine 5.0, VC sodium 5.0, phytic acid
5.0, phytate 5.0;
The cell normal growth is metabolized required agent, is made of amino acids, specifically: arginine 5.0, serine 5.0, sweet
Propylhomoserin 9.0, glutamic acid 1.0;
The preservative, is made of potassium sorbate and dehydroactic acid sodium, specifically: potassium sorbate 2.0, dehydroactic acid sodium
0.01;
The acceptable safety barrier of described preparation or auxiliary material, by polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP) structure
At specifically: polyethylene glycol 400 0.001, Macrogol 4000 0.0001, polyethylene glycol 10000 0.001, poly- second two
Alcohol 20,000 0.001, PVP K15 0.001, PVP K30 0.001, PVP K60 0.001 and PVP K90 0.001;
Wherein, the biological tinnitus is releived the Nantural non-toxic Chinese herbal medicine alcohol extract in agent, which is characterized in that the natural nothing
Component that malicious Chinese herbal medicine alcohol extract contains following mass fraction is simultaneously made by following processes: 30 parts of rhizoma acori graminei, 30 parts of Rhizoma Gastrodiae,
40 parts of pueraria lobata, 40 parts of Radix Salviae Miltiorrhizae, 20 parts of Radix Astragali, 30 parts of Radix Notoginseng, 10 parts of Radix Angelicae Sinensis, 30 parts of radix saposhnikoviae, 15 parts of schizonepeta, 20 parts of peppermint, the root of Dahurain angelica
15 parts, 15 parts of caulis akebiae, 15 parts of Centipeda minima;Its process of preparing includes: to weigh the formula Chinese medicine, and being crushed to partial size is rice
The ethyl alcohol for being equivalent to the concentration of 5-20 times of quality of mixture as 10-90%(V/V) is added, then in positive pressure in the particle of grain size
It extracts more than a few hours, is collected by filtration under the conditions of set temperature is 70-103 DEG C in multi-functional extractor in 0.015Mpa environment
Extracting solution is up to the alcohol extract.
Embodiment 3
Tinnitus and the formulation products with ear healthcare function, the substantially same embodiment of preparation method are used for provided by the present embodiment
1, only adjustment member formula is as follows:
Said preparation is liquor, and the total mass concentration of effective ingredient is 20%, and surplus is solvent, pH=8.0;Each composition in effective ingredient
In terms of mass fraction, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 80.0, Rhizoma Acori Graminei extract 9.0, kudzu root extract 6.0, pellet
Conopsea extraction 6.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 6.0, VB2 1.0, niacinamide 10.0, VB5 6.0, VB6 6.0, niacin 5.0, Vc 5.0, Ve 1.0;
Biotin 0.001, Co-Q10 1.0, Coenzyme I 0.001, Coenzyme I I 0.001;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 9.0, allantoin 0.001;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 0.01 and cromoci
5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
10.0, notoginseng total saponin/glycosides 0.001, VB12 10.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically: zinc gluconate 0.01, lactic acid
Zinc 0.01, zinc citrate 0.01;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically: taurine 0.01, VC sodium 0.01, phytic acid
0.01, phytate 0.01;
The cell normal growth is metabolized required agent, is made of amino acids, lactic acid and inositol, specifically:
Arginine 0.001, serine 0.001, glycine 0.001, glutamic acid 0.001, glutamine 0.01, lactic acid 0.01, paddy
Propylhomoserin sodium 0.01, inositol 0.01;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, Carbenoxolone Sodium and sodium propionate, tool
For body: potassium sorbate 0.01, dehydroactic acid sodium 2.0, potassium cinnamate 0.01, glycyrrhizic acid 0.05, Carbenoxolone Sodium 0.01, sodium propionate
0.01;
The acceptable safety barrier of described preparation or auxiliary material, by polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP) structure
At specifically: polyethylene glycol 400 0.5, Macrogol 4000 11.0, polyethylene glycol 10000 0.2, PEG 20000
0.3, PVP K15 0.3, PVP K30 0.2, PVP K60 0.5 and PVP K90 9.0;
Wherein, the biological tinnitus is releived the Nantural non-toxic Chinese herbal medicine alcohol extract in agent, which is characterized in that the natural nothing
Component that malicious Chinese herbal medicine alcohol extract contains following mass fraction is simultaneously made by following processes: 90 parts of rhizoma acori graminei, 90 parts of Rhizoma Gastrodiae,
75 parts of pueraria lobata, 75 parts of Radix Salviae Miltiorrhizae, 55 parts of Radix Astragali, 60 parts of Radix Notoginseng, 50 parts of Radix Angelicae Sinensis, 70 parts of radix saposhnikoviae, 70 parts of schizonepeta, 80 parts of peppermint, the root of Dahurain angelica
50 parts, 50 parts of caulis akebiae, 90 parts of Centipeda minima;Its process of preparing includes: to weigh the formula Chinese medicine, and being crushed to partial size is rice
The ethyl alcohol for being equivalent to the concentration of 5-20 times of quality of mixture as 10-90%(V/V) is added, then multi-functional in the particle of grain size
Set temperature is extracted more than a few hours under the conditions of being 50-96 DEG C in extractor, and extracting solution is collected by filtration up to the alcohol extract.
Embodiment 4
Tinnitus and the formulation products with ear healthcare function, the substantially same embodiment of preparation method are used for provided by the present embodiment
1, only adjustment member formula is as follows:
Said preparation is liquor, and the total mass concentration of effective ingredient is 3%, and surplus is solvent, pH=4.0;Each composition in effective ingredient
In terms of mass fraction, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 10.0, Rhizoma Acori Graminei extract 1.0, kudzu root extract 1.0, pellet
Conopsea extraction 1.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 3.0, VB2 0.5, niacinamide 5.0, VB5 3.0, VB6 3.0, niacin 3.0, Vc 3.0, Ve 0.5;
Biotin 0.5, Co-Q10 0.5, Coenzyme I 1.0, Coenzyme I I 1.0;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 4.0, allantoin 1.0;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 3.0 and cromoci
2.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of notoginseng total saponin/glycosides and VB12, specifically: notoginseng total saponin/glycosides 1.0, VB12
5.0;
The intelligence hardening agent is zinc gluconate, specifically: zinc gluconate 2.0;
The antioxidant is taurine;Specifically: taurine 3.0;
The cell normal growth is metabolized required agent, is made of amino acids, sodium lactate and inositol, specifically: arginine
3.0, serine 3.0, glycine 5.0, glutamic acid 0.5, glutamine 4.0, sodium lactate 3.0, sodium glutamate 2.0, inositol 3.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, Carbenoxolone Sodium and calcium propionate, tool
For body: potassium sorbate 1.0, dehydroactic acid sodium 1.0, potassium cinnamate 1.0, glycyrrhizic acid 0.5, Carbenoxolone Sodium 2.0, calcium propionate 1.0;
The acceptable safety barrier of described preparation or auxiliary material, are made of, specifically: polyethylene glycol polyethylene glycol (PEG)
4000 3.0。
Embodiment 5
Tinnitus and the formulation products with ear healthcare function, the substantially same embodiment of preparation method are used for provided by the present embodiment
1, only adjustment member formula is as follows:
Said preparation is gelling agent, and the total mass concentration of effective ingredient is 9%, and surplus is solvent, pH=5.5;In effective ingredient respectively at
Part in terms of mass fraction, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 30.0, Rhizoma Acori Graminei extract 3.0, kudzu root extract 2.0, pellet
Conopsea extraction 2.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 1.0, VB2 0.1, niacinamide 1.0, VB5 1.0, VB6 1.0, niacin 1.0, Vc 0.5, Ve 0.05;
Biotin 0.01, Co-Q10 0.5;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 3.0, allantoin 0.01;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 0.5 and cromoci
0.05;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
4.0, notoginseng total saponin/glycosides 0.01, VB12 2.0;
The intelligence hardening agent is zinc gluconate, specifically: zinc gluconate 0.05;
The antioxidant is taurine;Specifically: taurine 1.0;
The cell normal growth is metabolized required agent, is made of amino acids, lactic acid class and inositol, specifically:
Arginine 1.0, serine 1.0, glycine 2.0, glutamic acid 0.01, glutamine 1.0, lactic acid 1.0, sodium lactate 1.0, paddy
Propylhomoserin sodium 1.0, inositol 1.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, Carbenoxolone Sodium and sodium propionate, tool
For body: potassium sorbate 0.05, dehydroactic acid sodium 0.2, potassium cinnamate 0.05, glycyrrhizic acid 0.5, Carbenoxolone Sodium 0.05, sodium propionate
0.05;
The acceptable safety barrier of described preparation or auxiliary material, by polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), xanthan
Glue and sodium alginate are constituted, specifically: PEG 20000 6.0, PVP K90 4.0, xanthan gum 2.0 and sodium alginate
1.5。
Embodiment 6
Tinnitus and the formulation products with ear healthcare function are used for provided by the present embodiment, preparation method to be with embodiment 1, only
Adjustment member formula is as follows:
Said preparation is liquor, and the total mass concentration of effective ingredient is 12%, and surplus is water, adjusts pH=6.0;In effective ingredient respectively at
Part in terms of mass fraction, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 50.0, Rhizoma Acori Graminei extract 5.0, kudzu root extract 3.0, pellet
Conopsea extraction 3.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 2.0, VB2 0.03, niacinamide 4.0, VB5 2.0, VB6 2.0, niacin 2.0;
Biotin 0.05, Co-Q10 0.5;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 4.0, allantoin 0.05;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 2.0 and cromoci
0.5;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
8.0, notoginseng total saponin/glycosides 0.08, VB12 4.0;
The intelligence hardening agent is zinc gluconate, specifically: zinc gluconate 0.8;
The antioxidant is taurine;Specifically: taurine 2.0;
The cell normal growth is metabolized required agent, is made of amino acids, lactic acid class and inositol, specifically:
Arginase 12 .0, serine 2.0, glycine 4.0, glutamic acid 0.1, glutamine 5.0, lactic acid 2.0, sodium lactate 2.0, paddy
Propylhomoserin sodium 2.0, inositol 2.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium and potassium cinnamate, specifically: potassium sorbate 0.1, dehydrogenation
Sodium acetate 0.2, potassium cinnamate 0.1;
The acceptable safety barrier of described preparation or auxiliary material, by polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP) structure
At specifically: polyethylene glycol 10000 2.0 and PVP K90 6.0.
Embodiment 7
Tinnitus and the formulation products with ear healthcare function are used for provided by the present embodiment, preparation method to be with embodiment 1, only
Adjustment member formula is as follows:
Said preparation is liquor, and the total mass concentration of effective ingredient is 16%, and surplus is water, adjusts pH=5.5;In effective ingredient respectively at
Part in terms of mass fraction, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 70.0, Rhizoma Acori Graminei extract 7.0, kudzu root extract 5.0, pellet
Conopsea extraction 5.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 4.0, VB2 0.03, niacinamide 8.0, VB5 4.0, VB6 4.0, niacin 4.0;
Biotin 0.06;
The cell-protecting, is made of allantoin, specifically: allantoin 1.5;
The cellular agonist, is made of cromoci, specifically: cromoci 4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of VB12, specifically: VB12 8.0;
The intelligence hardening agent is zinc gluconate, specifically: zinc gluconate 3.0;
The antioxidant is taurine;Specifically: taurine 4.0;
The cell normal growth is metabolized required agent, is made of inositol, specifically: inositol 4.0;
The preservative, is made of potassium sorbate, specifically: potassium sorbate 1.5;
The acceptable safety barrier of described preparation or auxiliary material, are made of, specifically: PVP polyvinylpyrrolidone (PVP)
K90 2.0。
The test evaluation method of reference implementation example 1, then 140 20-65 years old ages, the course of disease -20 years 1 week are selected at random really
7 groups are arranged in the different volunteer of the tinnitus severity examined, and every group of 20 volunteers, Application Example 1 ~ 7 is made respectively
Standby formulation products carry out drop ear or apply ear experiment.
Usage and dosage: the same.Efficacy evaluation is carried out after 2 months on probation.
The preparation effect that statistical result shows prepared by embodiment 1 is best, and total effective rate is 100.0%(P < 0.05);Implement
Preparation effect prepared by example 2 is worst, and total effective rate is 55.0%(P < 0.05);It is other successively are as follows:
The total effective rate of embodiment 3 is 95.0%(P < 0.05);The total effective rate of embodiment 4 is 90.0%(P < 0.05);
The total effective rate of embodiment 5 is 85.0%(P < 0.05);The total effective rate of embodiment 6 is 80.0%(P < 0.05);
The total effective rate of embodiment 7 is 70.0%(P < 0.05).
Embodiment 8
Tinnitus and the formulation products with ear healthcare function are used for provided by the present embodiment, preparation method to be with embodiment 1, only
Adjustment member formula is as follows:
Said preparation is liquor, and the total mass concentration of effective ingredient is 8%, and surplus is water, adjusts pH=5.0;In effective ingredient respectively at
Part in terms of mass fraction, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 50.0, Rhizoma Acori Graminei extract 5.0, kudzu root extract 3.0, pellet
Conopsea extraction 3.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 0.2, VB2 0.8, niacinamide 0.01, VB5 0.01, VB6 0.01, niacin 0.01, Vc 0.01, Ve
0.001;
Biotin 1.0, Co-Q10 0.001, Coenzyme I 2.0, Coenzyme I I 2.0;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 0.01, allantoin 2.0;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 5.0 and cromoci
0.001;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
4.0, notoginseng total saponin/glycosides 2.0, VB12 0.01;
The intelligence hardening agent is zinc gluconate, specifically: zinc gluconate 4.0;
The antioxidant is taurine;Specifically: taurine 5.0;
The cell normal growth is metabolized required agent, is made of amino acids and inositol, specifically: arginine 5.0, serine
5.0, glycine 9.0, glutamic acid 1.0, inositol 6.0;
The preservative, is made of potassium sorbate and dehydroactic acid sodium, specifically: potassium sorbate 2.0, dehydroactic acid sodium
0.01。
Embodiment 9
Tinnitus and the formulation products with ear healthcare function are used for provided by the present embodiment, preparation method to be with embodiment 1, only
Adjustment member formula is as follows:
Said preparation is liquor, and the total mass concentration of effective ingredient is 8%, and surplus is water, adjusts pH=5.0;In effective ingredient respectively at
Part in terms of mass fraction, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 60.0, Rhizoma Acori Graminei extract 6.0, kudzu root extract 4.0, pellet
Conopsea extraction 4.0;The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 6.0, VB2 1.0, niacinamide 10.0, VB5 6.0, VB6 6.0, niacin 5.0, Vc 5.0, Ve 1.0;
Biotin 0.001, Co-Q10 1.0, Coenzyme I 0.001, Coenzyme I I 0.001;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 9.0, allantoin 0.001;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 0.01 and cromoci
5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
1.0, notoginseng total saponin/glycosides 0.001, VB12 10.0;
The intelligence hardening agent is zinc gluconate, specifically: zinc gluconate 0.01;
The antioxidant is taurine;Specifically: taurine 0.01;
The cell normal growth is metabolized required agent, is made of amino acids and inositol, specifically:
Arginine 0.001, serine 0.001, glycine 0.001, glutamic acid 0.001, inositol 0.01;
The preservative, is made of potassium sorbate and dehydroactic acid sodium, specifically: potassium sorbate 0.01, dehydroactic acid sodium
2.0。
The test evaluation method of reference implementation example 1 selects the ear made a definite diagnosis at 80 20-66 years old ages, the course of disease -22 years 1 week at random
2 groups are arranged in the different volunteer of severity of ringing, and every group of 40 volunteers, Application Example 8, embodiment 9 are made respectively
Standby different ratio but the formulation products of identical mass percentage concentration carry out drop ear experiment.
Usage: the liquid outlet of preparation is directed at ear canal, instilled in ear, a moment is massaged after drop by cephalomenia side;Dosage: 1-3
Drop/time, 1-3 times/day.Efficacy evaluation is carried out after 2 months on probation.
The preparation effect that statistical result shows prepared by embodiment 9 is best, and total effective rate is 95.0%(P < 0.05), embodiment
The preparation effect of 8 preparations is weaker than embodiment 9, and total effective rate is 87.5%(P < 0.05).
Based on the above embodiments and the statistics of prolonged application effect show the present invention have it is following more outstanding the utility model has the advantages that
(1) targeting is given, and effect is obvious;Maintenance combines, based on supporting;Outer suppression disease, inside repairs skin;Have disease that can disappear, it is ill-mannered can
It is anti-;The mitigation and alleviation that can be widely used for the symptoms such as tinnitus caused by a variety of causes, ear itching, otalgia, are mainly used for nerve, blood
The mitigation and alleviation of the ears source such as pipe hardenability, function degeneration property tinnitus symptom;The effect feature of this product is, light according to the state of an illness
Weight length, effect performance is different, if newly sending out tinnitus serious, general medication 1-4 weeks, tinnitus symptom can be substantially reduced or disappears
It loses, also has and newly send out tinnitus serious and drip the case just to be disappeared with 1-2 weeks tinnitus symptom;If medical history is longer, the long period is needed to treat
With conditioning or rehabilitation;Generally to serious tinnitus patient, for the first time using having positive effect, more serious person's sensory effect is more obvious,
Longer using the time, effect is more obvious.
(2) highly-safe, it is widely applicable.Invention formulation has no toxic side effect, is non-stimulated, without allergy, is suitable for almost institute
There is crowd.
(3) easy to use, excellent effect.Product of the present invention is unlike traditional drug, and there are many toxic side effect and limits
Factor processed is operated without health care professional, can be used whenever and wherever possible;And it is quick, and can be used for a long time.
(4) invention formulation not only has the function for the treatment of the ears disease such as tinnitus, can also be to ear cranial nerve muscle cell and micro-
Blood circulation system has important conditioning and rehabilitative action;Simultaneously, it may have Nutritional Nursing Care ear brain and the function for keeping ear brain pleasant
Effect, so, it also can be used as the common ear health treatment of ordinary people.
Claims (10)
1. a kind of preparation with treatment tinnitus and ear healthcare function, it is characterised in that: said preparation include biological tinnitus releive agent,
Cell physiological function regulator, cell-protecting, cellular agonist, promoting blood circulation and removing obstruction in channels dose, intelligence hardening agent, antioxidant, cell
Normal growth is metabolized required agent;
The biology tinnitus is releived agent, and including but not limited to Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, pueraria lobata extract
Object and Salvia root P.E, selection one of which or several arbitrary proportion mixtures;
The cell physiological function regulator makees the physiological function of the relevant soma of ear organ with important adjusting
With being made of vitamins and coenzyme substance;
The cell-protecting, including but not limited to trehalose, allantoin, selection one of which or the mixing of several arbitrary proportions
Object;
The cellular agonist, including but not limited to ATP disodium, cromoci, selection one of which or several arbitrary proportions are mixed
Close object;
Described promoting blood circulation and removing obstruction in channels dose, including but not limited to Notogineng Extract, notoginseng total saponin/glycosides, VB12, selection are one of or several
Kind arbitrary proportion mixture;
The intelligence hardening agent, including but not limited to zinc gluconate, zinc lactate, zinc citrate, selection are one of or several
Arbitrary proportion mixture;
The antioxidant, including but not limited to taurine, VC sodium, phytic acid, phytate, selection one of which or several any ratios
Example mixture;
The cell normal growth is metabolized required agent, including but not limited to amino acids, lactic acid class, inositol, and selection is one of
Or several arbitrary proportion mixtures.
2. as described in claim 1 for treating tinnitus and the preparation with ear healthcare function, which is characterized in that said preparation includes
Preservative;The preservative, including but not limited to potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate, third
Hydrochlorate, selection one of which or several arbitrary proportion mixtures.
3. as described in claim 1 for treating tinnitus and the preparation with ear healthcare function, which is characterized in that said preparation includes
Acceptable safety barrier or auxiliary material;The acceptable safety barrier or auxiliary material, including but not limited to different molecular weight size
Polyethylene glycol (PEG), different molecular weight size polyvinylpyrrolidone (PVP) or/and other excipient, selection wherein one
Kind or several arbitrary proportion mixtures;
The polyethylene glycol of the different molecular weight size refers to that molecular weight is the polyethylene glycol of 400-20000 dalton;
The PVP of the different molecular weight size, including but not limited to PVP K15, PVP K30, PVP K60 and PVP K90, selection
One of or several arbitrary proportion mixtures.
4. preparation as described in claim 1, it is characterised in that: said preparation is liquor, and the total mass concentration of effective ingredient is
0.5-20.0%, surplus are solvent;Each composition is in terms of mass fraction in effective ingredient, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 1.0-80.0, Rhizoma Acori Graminei extract 0.01-9.0, pueraria lobata extract
Object 0.01-6.0, Salvia root P.E 0.01-6.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 0.01-6.0, vitamin V B2 0.001-1.0, niacinamide 0.01-10.0, VB5 0.01-6.0, VB6
0.01-6.0, niacin 0.01-5.0, Vc 0.01-5.0, Ve 0.001-1.0;
Biotin 0.001-1.0, Co-Q10 0.001-1.0, Coenzyme I 0.001-2.0, Coenzyme I I 0.001-2.0;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 0.01-9.0, allantoin 0.001-
2.0;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 0.01-5.0, cell color
Plain C 0.001-5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
0.01-10.0, notoginseng total saponin/glycosides 0.001-2.0, VB12 0.01-10.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically: zinc gluconate 0.01-4.0,
Zinc lactate 0.01-4.0, zinc citrate 0.01-4.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically: taurine 0.01-5.0, VC sodium 0.01-
5.0, phytic acid 0.01-5.0, phytate 0.01-5.0;
The cell normal growth is metabolized required agent, is made of amino acids, lactic acid class and inositol, specifically:
Arginine 0.001-5.0, serine 0.001-5.0, glycine 0.001-9.0, glutamic acid 0.001-1.0, glutamine
0.01-8.0, lactic acid 0.01-5.0, sodium lactate 0.01-5.0, sodium glutamate 0.01-3.0;Inositol 0.01-6.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate and propionate, tool
For body: potassium sorbate 0.01-2.0, dehydroactic acid sodium 0.01-2.0, potassium cinnamate 0.01-2.0, glycyrrhizic acid 0.01-1.0, sweet
Oxalates 0.01-3.0, propionate 0.01-2.0.
5. preparation according to claim 4, it is characterised in that: the preparation is liquor, the total mass concentration of effective ingredient
For 1.0-18.0%, surplus is water;Each composition is in terms of mass fraction in effective ingredient, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 2.0-76.0, Rhizoma Acori Graminei extract 0.01-8.0, pueraria lobata extract
Object 0.01-5.0, Salvia root P.E 0.01-5.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 0.01-5.0, vitamin V B2 0.001-0.5, niacinamide 0.01-8.0, VB5 0.01-5.0, VB6
0.01-5.0, niacin 0.01-4.0, Vc 0.01-4.0, Ve 0.01-1.0;Biotin 0.001-0.60, Co-Q10 0.01-
1.0, Coenzyme I 0.01-1.20, Coenzyme I I 0.01-1.60;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 0.01-6.0, allantoin 0.01-
1.0;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 0.01-4.0, cell color
Plain C 0.01-4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
0.01-8.0, notoginseng total saponin/glycosides 0.01-1.80, VB12 0.01-8.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically: zinc gluconate 0.01-3.0,
Zinc lactate 0.01-3.0, zinc citrate 0.01-3.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically: taurine 0.01-4.0, VC sodium 0.01-
4.0, phytic acid 0.01-4.0, phytate 0.01-4.0;
The cell normal growth is metabolized required agent, is made of amino acids, lactic acid class and inositol, specifically: arginine
0.001-4.0, serine 0.001-3.0, glycine 0.001-6.0, glutamic acid 0.01-1.0, glutamine 0.01-5.0, cream
Sour 0.01-3.0, sodium lactate 0.01-4.0, sodium glutamate 0.01-2.0;Inositol 0.01-5.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate and propionate, tool
For body: potassium sorbate 0.01-1.80, dehydroactic acid sodium 0.01-1.80, potassium cinnamate 0.01-1.80, glycyrrhizic acid 0.01-
0.80, glycyrrhetate 0.01-2.0, propionate 0.01-1.80.
6. a kind of preparation treated tinnitus and have ear healthcare function as claimed in claim 5, which is characterized in that the preparation,
The total mass concentration of effective ingredient is 8.0%;Each composition is in terms of mass fraction in effective ingredient, specifically:
The biology tinnitus is releived agent, is mentioned by Nantural non-toxic Chinese herbal medicine alcohol extract, Rhizoma Acori Graminei extract, kudzu root extract and Radix Salviae Miltiorrhizae
Object is taken to constitute, specifically: Nantural non-toxic Chinese herbal medicine alcohol extract 40.0, Rhizoma Acori Graminei extract 5.0, kudzu root extract 3.0, pellet
Conopsea extraction 3.0;
The cell physiological function regulator, is made of vitamins and coenzyme class, specifically:
Vitamin V B1 5.0, vitamin V B2 0.5, niacinamide 8.0, VB5 4.0, VB6 3.0, niacin 4.0, Vc 1.0, Ve
0.4;Biotin 0.6, Co-Q10 0.6, Coenzyme I 0.8, Coenzyme I I 0.9;
The cell-protecting, is made of trehalose and allantoin, specifically: trehalose 4.5, allantoin 0.9;
The cellular agonist is made of ATP disodium and cromoci, specifically: ATP disodium 4.0 and cromoci
4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically: Notogineng Extract
4.0, notoginseng total saponin/glycosides 0.6, VB12 8.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically: zinc gluconate 2.0, zinc lactate
3.0, zinc citrate 1.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically: taurine 1.0, VC sodium 2.0, phytic acid
2.0, phytate 2.0;
The cell normal growth is metabolized required agent, is made of amino acids, lactic acid class and inositol, specifically:
Arginine 4.0, serine 1.0, glycine 8.0, glutamic acid 0.9, glutamine 7.0, lactic acid 4.0, sodium lactate 4.0, paddy
Propylhomoserin sodium 2.0, inositol 4.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, dipotassium glycyrrhizinate and sodium propionate, tool
For body: potassium sorbate 1.0, dehydroactic acid sodium 0.8, potassium cinnamate 0.8, glycyrrhizic acid 0.5, dipotassium glycyrrhizinate 2.0, sodium propionate 0.9.
7. having the application of the preparation for the treatment of tinnitus and ear healthcare function as described in claim 1, which is characterized in that the preparation
For liquid formulation or solid formulation, application method are as follows: when being used for tinnitus or ear health care, liquid agent is passed through ear by cephalomenia side
Hole instills in external auditory canal, gently massages a moment, or solid-state agent uniformly smeared or cold compress near auricle and the basal part of the ear gently
Massage a moment, in terms of dosage, liquor be 1-3 drop/time, 1-3 times/day, every drop volume is 0.02-0.04mL;Solid-state agent is
0.1-2.0g/time, 1-2 times/day.
8. having the preparation method of the preparation for the treatment of tinnitus and ear healthcare function as described in claim 1, which is characterized in that specific
Include the following steps:
(1) effective ingredient in preparation is divided into 4 groups according to material properties and the convenience of preparation and easy property processed, weighs formula respectively
Middle dosage is spare, specifically:
First group, glycitols compound;
Second group, amino acids;
Third group, vitamin coenzymes class compound;
4th group, unclassified stores in addition to the solvents;
(2) second group of material weighed in step (1) is placed in reaction kettle, the solvent of part formulation amount, stirring is then added
Dissolution mixes, and stands, and mixture A is obtained after filtering and impurity removing;
(3) third group weighed in step (1) and the 4th group of material are placed in reaction kettle, the molten of part formulation amount is then added
Agent, stirring and dissolving mix, and stand, and mixture B is obtained after filtering and impurity removing;
(4) the mixture B of step (3) is slowly added into the mixture A of step (2), after the completion of addition, is added step (1)
In weighed first group of material, be eventually adding the solvent and auxiliary agent of remainder formula ratio, dissolution mixes, filtering and impurity removing, adjusts
PH=3.5 ~ 8.0, this is formulation products provided herein.
9. as claimed in claim 8 for treating the preparation method of the preparation of tinnitus and ear healthcare function, which is characterized in that step
(2), step (3), when carrying out dissolution in step (4) and mixing operation, operation temperature is not higher than 45 DEG C, is not less than 10 DEG C.
Nantural non-toxic Chinese herbal medicine alcohol extract 10. the biological tinnitus as described in claim 1,4,5,6 is releived in agent, feature exist
In component that the Nantural non-toxic Chinese herbal medicine alcohol extract contains following mass fraction is simultaneously made by following processes: stone Chang
30~90 parts of Pu, 30~90 parts of Rhizoma Gastrodiae, 40~75 parts of pueraria lobata, 40~75 parts of Radix Salviae Miltiorrhizae, 20~55 parts of Radix Astragali, 30~60 parts of Radix Notoginseng,
10~50 parts of Radix Angelicae Sinensis, 30~70 parts of radix saposhnikoviae, 15~70 parts of schizonepeta, 20~80 parts of peppermint, 15~50 parts of the root of Dahurain angelica, caulis akebiae 15~50
Part, 15~90 parts of Centipeda minima;Its process of preparing includes: to weigh the formula Chinese medicine, and being crushed to partial size is grain of rice size
Particle, be added be equivalent to 5-20 times of quality of mixture concentration be 10-90%(V/V) ethyl alcohol, then in include but is not limited to
It is small that number is extracted under the conditions of set temperature is 20-103 DEG C in multi-functional extractor in vacuum or/and normal pressure or/and positive pressure environment
When more than, extracting solution is collected by filtration up to the alcohol extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810854373.3A CN108939078A (en) | 2018-07-30 | 2018-07-30 | It is a kind of with treatment tinnitus and the preparation of ear healthcare function and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810854373.3A CN108939078A (en) | 2018-07-30 | 2018-07-30 | It is a kind of with treatment tinnitus and the preparation of ear healthcare function and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108939078A true CN108939078A (en) | 2018-12-07 |
Family
ID=64466531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810854373.3A Pending CN108939078A (en) | 2018-07-30 | 2018-07-30 | It is a kind of with treatment tinnitus and the preparation of ear healthcare function and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108939078A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101194983A (en) * | 2006-12-29 | 2008-06-11 | 周宣岩 | Dropping pills for treating sudden deafness and method for preparing the same |
CN101670057A (en) * | 2009-04-29 | 2010-03-17 | 吴清玲 | Compound ear dropping liquid for treating suppurative otitis media |
CN107661481A (en) * | 2017-11-20 | 2018-02-06 | 武汉市第三医院 | A kind of medicine for treating tinnitus and its production and use |
CN107753764A (en) * | 2017-11-22 | 2018-03-06 | 于丽 | A kind of Chinese medicine composition for treating tinnitus |
-
2018
- 2018-07-30 CN CN201810854373.3A patent/CN108939078A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101194983A (en) * | 2006-12-29 | 2008-06-11 | 周宣岩 | Dropping pills for treating sudden deafness and method for preparing the same |
CN101670057A (en) * | 2009-04-29 | 2010-03-17 | 吴清玲 | Compound ear dropping liquid for treating suppurative otitis media |
CN107661481A (en) * | 2017-11-20 | 2018-02-06 | 武汉市第三医院 | A kind of medicine for treating tinnitus and its production and use |
CN107753764A (en) * | 2017-11-22 | 2018-03-06 | 于丽 | A kind of Chinese medicine composition for treating tinnitus |
Non-Patent Citations (3)
Title |
---|
傅俊等: "都可喜治疗突发性耳聋的疗效观察", 《当代医学(学术版)》 * |
钟渠等: "耳鸣消液治疗耳鸣40例", 《河南中医》 * |
陈贵廷等: "《实用中西医结合诊断治疗学》", 31 July 1991, 中国医药科技出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106177408B (en) | Skin anti-allergy traditional Chinese medicine composition, traditional Chinese medicine preparation, mask and preparation method | |
CN105168090A (en) | Gromwell ointment and preparation method thereof | |
CN102836367B (en) | Bacteria-resisting, inflammation-diminishing and itching-relieving traditional Chinese medicine composition and preparation method and application thereof | |
CN102139030A (en) | Oral Chinese herbal preparation for treating gingivitis and preparation method thereof | |
CN103182045A (en) | Medicine for treating tinea of feet and hands and preparation method thereof | |
CN111297961A (en) | Dong medicine for promoting wound healing | |
CN108143657A (en) | A kind of herbal mixture eye mask liquid and its preparation process | |
CN1709302A (en) | Chinese medicine formulation for treating chronic pelvic inflammation and its preparing method | |
CN116115707B (en) | Concentrated foam medicated bath liquid for preventing and treating cow hoof rot and preparation method thereof | |
CN102895316A (en) | Face cleanser for treating and preventing acne and preparation method thereof | |
CN108685754A (en) | A kind of auristilla for the ear function that relaxes for tinnitus and with strong ear | |
CN105147773A (en) | Traditional Chinese medicine composition with effect of restraining acne and preparation method and application of traditional Chinese medicine composition | |
CN102805800B (en) | Traditional Chinese medicine composition for treating neurodermatitis | |
CN108939078A (en) | It is a kind of with treatment tinnitus and the preparation of ear healthcare function and preparation method thereof | |
CN108785384A (en) | A kind of Chinese medicine composition containing zinc and its preparation for treating acne | |
CN104435374B (en) | A kind of acupoint injection therapy liquid for the treatment of subjective tinnitus and preparation method thereof | |
CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
CN101129425B (en) | Traditional Chinese medicine for treating zoster | |
CN113181336A (en) | Traditional Chinese medicine composition and preparation for treating gynecological diseases and preparation method and application thereof | |
CN112237604A (en) | Traditional Chinese medicine incense for reducing epidemic infection and preparation process thereof | |
CN1219527C (en) | Ointment for curing acne and its preparation method | |
CN1107506C (en) | Medicine for treating tinea | |
CN108635572A (en) | It is a kind of to treat otitis and the auristilla and preparation method thereof for ear function of feeling well with clear ear | |
CN101601693B (en) | Externally used medicine for curing acne | |
CN101053593A (en) | Shenghong heat-clearing granule and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181207 |